Cytokinetics reported $37.15M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 266.96M 37.53M
Acceleron Pharma XLRN:US $ 336.2M 119.31M
Acorda Therapeutics ACOR:US $ 45.71M 71.06M
Amgen AMGN:US $ 6630M 518M
Arca Biopharma ABIO:US $ 66.93M 15.84M
Bayer BAYN:GR € 3389M 2161M
Biogen BIIB:US $ 1742M 524.5M
Brainstorm Cell Therapeutics BCLI:US $ 30.56M 5.37M
Bristol Myers Squibb BMY:US $ 11024M 42M
Capricor Therapeutics CAPR:US $ 38.08M 3.8M
Cytokinetics CYTK:US $ 37.15M 7.44M
Eisai 4523:JP Y 213082M 6097M
Eli Lilly And LLY:US $ 3220M 217.6M
Exelixis EXEL:US $ 492.46M 122.25M
Genocea Biosciences GNCA:US $ 60.4M 5.64M
Geron GERN:US $ 57.64M 26.11M
Halozyme Therapeutics HALO:US $ 446.97M 52.48M
Intra Cellular Therapies ITCI:US $ 121.03M 8.95M
Ligand Pharmaceuticals LGND:US $ 301.83M 269.98M
Novartis NOVN:VX SF 5117M 1316M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M